PFBT
RNAM

Parkside Financial Bank & Trust’s Avidity Biosciences RNAM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60
Closed -$4.33K – 2767
2025
Q4 		$4.33K Hold
60
– – ﹤0.01% 1851
2025
Q3 		$2.62K Hold
60
– – ﹤0.01% 1927
2025
Q2 		$1.7K Sell
60
-5
-8% -$149 ﹤0.01% 2052
2025
Q1 		$1.92K Buy
+65
New +$2.02K ﹤0.01% 1901

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Parkside Financial Bank & Trust's RNAM Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 60 shares — an estimated $4.33K sold.

Parkside Financial Bank & Trust first reported a position in RNAM in Q1 2025 and held it in 4 quarters. The position peaked at $4.33K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 60 Avidity Biosciences shares in Q1 2026, an estimated $4.33K.
  • Parkside Financial Bank & Trust first reported a position in Avidity Biosciences in Q1 2025 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Avidity Biosciences position peaked at $4.33K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.